RE-BVS – Piemonte Repository

Sfoglia per AUTORE
NERVIANI A
Collezione AOU Novara

Items : 13

Molecular portrait of chronic joint diseases: Defining endotypes toward personalized medicine. in Joint bone spine / Joint Bone Spine. 2024 May;91(3):105692. doi: 10.1016/j.jbspin.2024.105692. Epub 2024 Jan 19.

2024
AOU Novara

Ghirardi GM; Delrosso CA; Nerviani A; Boutet MA;

Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis. in Nature communications / Nat Commun. 2024 Mar 16;15(1):2398. doi: 10.1038/s41467-024-46564-6.

2024
AOU Novara

Nerviani A; Boutet MA; Ghirardi GM; Goldmann K; Sciacca E; Rivellese F; Pontarini E; Prediletto E; Abatecola F; Caliste M; Pagani S; Mauro D; Bellan M; Cubuk C; Lau R; Church SE; Hudson BM; Humby F; Bombardieri M; Lewis MJ; Pitzalis C;

Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review. in Cells / Cells. 2024 Apr 24;13(9):743. doi: 10.3390/cells13090743.

2024
AOU Novara

Perera J; Delrosso CA; Nerviani A; Pitzalis C;

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials. in The Lancet. Rheumatology / Lancet Rheumatol. 2023 Nov;5(11):e648-e659. doi: 10.1016/S2665-9913(23)00241-2.

2023
AOU Novara

Rivellese F; Nerviani A; Giorli G; Warren L; Jaworska E; Bombardieri M; Lewis MJ; Humby F; Pratt AG; Filer A; Gendi N; Cauli A; Choy E; McInnes I; Durez P; Edwards CJ; Buch MH; Gremese E; Taylor PC; Ng N; Cañete JD; Raizada S; McKay ND; Jadon D; Sainaghi PP; Stratton R; Ehrenstein MR; Ho P; Pereira JP; et alii...

Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Jan-Feb;39(1):132-138. doi: 10.55563/clinexprheumatol/xyylza. Epub 2020 Jun

2021
AOU Novara

Pirisi M; Sainaghi PP; Cantaluppi V; Avanzi GC; Molinari L; Castello LM; Pagani S; Salmi L; Gibbin A; Goegan F; Lewis M; Mauro D; Nerviani A; Quaglia M; Bellan M; Pitzalis C;

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. in Lancet (London, England) / Lancet. 2021 Jan 23;397(10271):305-317. doi: 10.1016/S0140-6736(20)32341-2.

2021
AOU Novara

Humby F; Durez P; Buch MH; Lewis MJ; Rizvi H; Rivellese F; Nerviani A; Giorli G; Mahto A; Montecucco C; Lauwerys B; Ng N; Ho P; Bombardieri M; Romão VC; Verschueren P; Kelly S; Sainaghi PP; Gendi N; Dasgupta B; Cauli A; Reynolds P; Cañete JD; Moots R; Taylor PC; Edwards CJ; Isaacs J; Sasieni P; Choy E; et alii...

Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target. in Disease markers / Dis Markers. 2021 Jan 13;2021:2854925. doi: 10.1155/2021/2854925. eCollection 2021.

2021
AOU Novara

Sainaghi PP; Bellan M; Nerviani A;

Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis? in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 Mar-Apr;38(2):343-349. doi: 10.55563/clinexprheumatol/tdf172. Epub 2019 Sep

2020
AOU Novara

Bellan M; Andreoli L; Nerviani A; Piantoni S; Avanzi GC; Soddu D; Hayden E; Pirisi M; Sainaghi PP;

Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review. in Autoimmunity reviews / Autoimmun Rev. 2020 Feb;19(2):102453. doi: 10.1016/j.autrev.2019.102453. Epub 2019 Dec 12.

2020
AOU Novara

Bellan M; Patrucco F; Barone-Adesi F; Gavelli F; Castello LM; Nerviani A; Andreoli L; Cavagna L; Pirisi M; Sainaghi PP;

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis. in Disease markers / Dis Markers. 2020 Jan 19;2020:1614627. doi: 10.1155/2020/1614627. eCollection 2020.

2020
AOU Novara

Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A;

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders. in Disease markers / Dis Markers. 2020 May 12;2020:2696173. doi: 10.1155/2020/2696173. eCollection 2020.

2020
ASL Novara
AOU Novara

Sola D; Marino P; Castello LM; Barbaglia MN; Salmi L; Minisini R; Rigamonti C; Burlone ME; Smirne C; Carriero A; Barini M; Nerviani A; Grimoldi F; Sguazzotti M; Giubertoni A; Ianniello A; Piccinino C; Dimagli A; Bellan M; Avanzi GC; Pirisi M; Sainaghi PP;

Superiority of a high loading dose of cholecalciferol to correct hypovitaminosis d in patients with inflammatory/autoimmune rheumatic diseases. in The Journal of rheumatology / J Rheumatol. 2013 Feb;40(2):166-72. doi: 10.3899/jrheum.120536. Epub 2012 Dec 15.

2013
AOU Novara

Sainaghi PP; Bellan M; Nerviani A; Sola D; Molinari R; Cerutti C; Pirisi M;

Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases. in Rheumatology international / Rheumatol Int. 2012 Nov;32(11):3365-72. doi: 10.1007/s00296-011-2170-x. Epub 2011 Nov 2.

2012
AOU Novara

Sainaghi PP; Bellan M; Carda S; Cerutti C; Sola D; Nerviani A; Molinari R; Cisari C; Avanzi GC;